In order to get physicians engaged and involved in accountable care organizations (ACOs), it is important to educate them on the mission and understand that the organization is looking to improve, not ration, care, Stephen Nuckolls, CEO of Coastal Carolina Quality Care, explained at the National Association of Accountable Care Organizations Spring 2016 Conference.
In order to get physicians engaged and involved in accountable care organizations (ACOs), it is important to educate them on the mission and understand that the organization is looking to improve, not ration, care, Stephen Nuckolls, CEO of Coastal Carolina Quality Care, explained at the National Association of Accountable Care Organizations Spring 2016 Conference.
Transcript (slightly modified)
What is the importance of getting physicians on board and involved in an ACO?
It's vitally important to get the physicians involved. They're the main drivers of care, especially in our organization. The business and finance types can help point the doctors in the direction where their costs may be higher, but it's vital to get the physicians involved because they are the ones who write the orders—order the tests—they're the ones who care for the patients and most effectively transform the care.
How do you get physicians engaged?
The first part of engagement is education: having them understand the mission and believe in the mission. It's very important for them to know that we're trying to improve care, and we're definitely not trying to ration care. And as we improve care, we can lower costs. I think that's the first part: to buy into the overall mission of the ACOs and the triple aim.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
How Mirdametinib Improves QOL for People With NF1-Associated Plexiform Neurofibromas
March 18th 2025Christopher L. Moertel, MD, University of Minnesota, discusses the trial data that helped get mirdametinib approved and what providers can do to keep measuring quality of life (QOL) improvements.
Read More